Valuation: Yield10 Bioscience, Inc.

Market Cap 229K 199K 186K 171K 322K 21.84M 327K 2.19M 859K 10.89M 861K 842K 35.92M P/E 2022
-0.6x
P/E 2023 -0.13x
Enterprise Value 2.34M 2.03M 1.9M 1.74M 3.29M 223M 3.34M 22.38M 8.76M 111M 8.79M 8.59M 367M EV / Sales 2022
14.6x
EV / Sales 2023 83x
Free-Float
86%
Yield 2022 *
-
Yield 2023 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
45.12
5 years 0
Extreme 0
210.24
10 years 0
Extreme 0
8,927.99
Manager TitleAgeSince
Chief Executive Officer 68 2016-10-16
Director of Finance/CFO 70 2014-11-02
Director TitleAgeSince
Director/Board Member 68 2009-07-06
Chairman 69 2011-11-07
Director/Board Member 63 2017-03-01
Date Insider Type Main position Quantity % Market Cap.
8/15/24 Tax

Chief Technology Officer

877 0.1365%
8/15/24 Tax

Chief Financial Officer

731 0.1138%
8/15/24 Tax

Investor Relations Manager

731 0.1138%
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%0.00%0.00%-100.00% 73
+0.93%+0.14%-2.06%+14.33% 48.22B
-2.71%-2.99%+398.09%+472.12% 38.79B
-0.71%+9.45%+27.90%+7.89% 38.41B
-0.71%-3.72%+4.94%+52.45% 34.88B
-2.41%+1.96%+11.68%+38.17% 29.19B
-0.66%-2.73%+35.50%+122.17% 16B
-0.19%-3.93% - - 16.05B
+0.32%-0.51%+2.45%+15.70% 13.53B
-3.15%-6.14%-4.82%-36.90% 12.22B
Average +989.10%-0.60%+52.63%+65.10% 24.73B
Weighted average by Cap. -0.91%+0.15%+75.54%+103.64%

Financials

2022 2023
Net sales 450K 391K 365K 335K 632K 42.89M 643K 4.31M 1.69M 21.39M 1.69M 1.65M 70.55M 60K 52.15K 48.68K 44.69K 84.27K 5.72M 85.74K 574K 225K 2.85M 225K 220K 9.41M
Net income -13.57M -11.79M -11.01M -10.11M -19.05M -1.29B -19.39M -130M -50.83M -645M -50.96M -49.83M -2.13B -14.46M -12.56M -11.73M -10.77M -20.3M -1.38B -20.66M -138M -54.16M -687M -54.3M -53.09M -2.27B
Net Debt -1.7M -1.47M -1.38M -1.26M -2.38M -162M -2.43M -16.24M -6.36M -80.66M -6.37M -6.23M -266M 2.11M 1.83M 1.71M 1.57M 2.96M 201M 3.02M 20.19M 7.91M 100M 7.93M 7.75M 331M
Logo Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Employees
29
Date Price Change Volume

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YTENQ Stock